
• Professor and Doctoral Supervisor at Sun Yat-sen University Cancer Prevention and Treatment Center, South China National Key Laboratory for Malignant Tumor Prevention and Treatment
• PhD in Immunology, University of Michigan
• Postdoctoral Fellow, Harvard Medical School
• Selected as Leading Talent of the “Ten Thousand Talents Plan” and for the “Overseas High-Level Talent Recruitment Program”
Long-term engagement in the development and clinical application of immunotherapy drugs for solid tumors. Research results published in Nature, Cell, Nature Medicine, Cell Research, JCI, PNAS, and other academic journals. Completed the translation of multiple patents. Developed novel immunotherapy approaches and drugs including “personalized TCR-T cell therapy,” “TCR-T cell therapy reversing the solid tumor microenvironment,” and “TAL-T cell therapy,” which have entered Phase I clinical trials.